TheraRadar

Pharma Intelligence, Simplified

Data updated: Mar 10, 2026

MOXATAG

AMOXICILLIN
Approved 2008-01-23
1
Indication
--
Phase 3 Trials
18
Years on Market

Details

Status
Discontinued
First Approved
2008-01-23
Routes
ORAL
Dosage Forms
TABLET, EXTENDED RELEASE

Companies

Active Ingredient: AMOXICILLIN

MOXATAG Approval History

Loading approval history...

What MOXATAG Treats

1 FDA approvals

Originally approved for its first indication in 2008 .

  • Other (1)
๐Ÿ”ฌ

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...
โญ

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
๐Ÿ“Š

Trial Timeline

Full development history with FDA approval milestones

Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

MOXATAG FDA Label Details

Pro

MOXATAG Patents & Exclusivity

Latest Patent: May 2027

Patents (3 active)

US8299052 Expires May 7, 2027
US8778924 Expires Dec 8, 2026
US8357394 Expires Dec 8, 2026
Source: FDA Orange Book

Want competitive intelligence?

See who's developing similar drugs and track their progress

View Pipeline Dashboard

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.